Eating on GLP-1 · Article

Nausea on Ozempic, Wegovy or Zepbound: What to Eat and What to Avoid

Why semaglutide and tirzepatide cause nausea, how long it lasts according to the labels, what to eat to ease it, and which warning signs mean calling your prescriber.

If you have nausea on semaglutide (Ozempic, Wegovy) or tirzepatide (Zepbound, Mounjaro), what usually helps most is eating small amounts often and slowly, stopping at the first sign of fullness, choosing bland, low-fat foods, sipping fluids and not lying down right after a meal. Nausea is the most common side effect of these medications. It shows up mostly around dose increases, and it’s usually mild to moderate and temporary. If you’re vomiting over and over, can’t keep fluids down or have severe stomach pain that won’t go away, call your prescriber right away.

In 30 seconds

  • Nausea in the weight-management trials: 44% on Wegovy (placebo: 16%); 25%, 29% and 28% on Zepbound 5, 10 and 15 mg (placebo: 8%).
  • In the EU prescribing information for Wegovy, the median duration was 8 days for nausea and 2 days for vomiting.
  • With semaglutide (STEP 1 to 3), the share of people with nausea peaked around week 20 and fell afterward.
  • With semaglutide, 98.1% of digestive side effects were mild or moderate.
  • Stopped treatment because of digestive side effects: 4.3% on Wegovy (placebo: 0.7%); 1.9%, 3.3% and 4.3% on Zepbound (placebo: 0.5%).

I built this guide from the US prescribing information and Medication Guides for Wegovy and Zepbound, two analyses of the STEP and SURMOUNT trials, the 2025 joint advisory on nutrition and GLP-1 therapy from four US medical and nutrition societies, and general guidance on nausea. The full eating plan is in my guide to what to eat on GLP-1 medications. On names: Ozempic is semaglutide and Mounjaro is tirzepatide, both approved in the US for type 2 diabetes, each with its own label. Wegovy and Zepbound are the same molecules approved for weight management. I lead with their figures because they come from weight-management trials.

Why these medications cause nausea

There are two mechanisms.

Your stomach empties more slowly. The Wegovy label says semaglutide delays gastric emptying, and the Zepbound label says tirzepatide delays gastric emptying, with the largest delay after the first dose and a diminishing effect over time. That’s why a large or fatty meal feels heavier than it used to. The 2025 advisory adds that more fluid foods with fewer calories and more water, such as some fruits and vegetables, may leave the stomach faster.

The drug also acts on the brain. A 2026 opinion article in Frontiers in Endocrinology explains that GLP-1 agonists bind to receptors in the brainstem, including the area postrema, a region that picks up nausea signals. So nausea doesn’t depend only on what’s in your stomach: the advisory notes it often shows up in the morning or after many hours without eating.

Treatment starts at a low dose that goes up in steps, following the label schedule your prescriber uses. Nausea clusters right around those steps.

How common nausea is, and how long it lasts

On both US labels, nausea tops the list of common adverse reactions. These are the figures from the weight-management trials:

Wegovy (semaglutide 2.4 mg) Zepbound (tirzepatide 5, 10 and 15 mg)
Nausea 44% (placebo: 16%) 25%, 29% and 28% (placebo: 8%)
Vomiting 24% (placebo: 6%) 8%, 11% and 13% (placebo: 2%)
Diarrhea 30% (placebo: 16%) 19%, 21% and 23% (placebo: 8%)
Severe gastrointestinal reactions 4.1% (placebo: 0.9%) 1.7%, 2.5% and 3.1% (placebo: 1%)
Stopped treatment because of digestive side effects 4.3% (placebo: 0.7%) 1.9%, 3.3% and 4.3% (placebo: 0.5%)
Median duration of nausea 8 days (EU prescribing information) Not reported

Sources: US labels for Wegovy (Table 3 and sections 5.6 and 6.1; three trials of up to 68 weeks in adults; the label’s summary paragraph rounds vomiting to 25%) and Zepbound (Table 1 and sections 5.2 and 6.1; two trials of up to 72 weeks in adults with and without type 2 diabetes). The median duration comes from the EU prescribing information for Wegovy; the US label doesn’t report durations. In people with type 2 diabetes, the Mounjaro label reports nausea in 12%, 15% and 18% on 5, 10 and 15 mg, versus 4% on placebo, and the Ozempic label 15.8% and 20.3% on 0.5 mg and 1 mg, versus 6.1%.

  • It passes. In the EU prescribing information for Wegovy, the median duration was 8 days for nausea and 2 days for vomiting.
  • It clusters around dose increases. In the pooled analysis of STEP 1 to 3, the share of people with nausea peaked around week 20 and fell afterward. The Zepbound label says most nausea, vomiting and diarrhea occurred during dose escalation and decreased over time.
  • It’s usually mild. In the tirzepatide weight-management trial described in the EU prescribing information for Mounjaro, digestive side effects were mild in 60.8% of cases and moderate in 34.6%. With semaglutide, in STEP 1 to 3, 98.1% were mild or moderate. The US labels count the severe ones instead, as in the table.
  • These numbers don’t compare the drugs. They come from different trials, with different populations and durations. The US labels themselves warn that rates from one drug’s trials can’t be directly compared with another’s.

What tends to help with nausea

I haven’t found trials that test these measures in people taking GLP-1 medications. They’re practical recommendations from the 2025 advisory, the Frontiers article, and general guidance on nausea from the UK’s NHS, MedlinePlus and the National Cancer Institute.

  • Small, frequent portions. The advisory suggests a small breakfast, then something small every 3 to 4 hours. MedlinePlus talks about 6 to 8 small meals instead of 3 large ones.
  • Eat slowly and stop at the first sign of fullness. Saving the rest for later is completely fine.
  • Go easy on fat and fried food. The advisory also suggests avoiding very high-fiber foods in the first few days of treatment.
  • Skip very sweet or spicy food if it bothers you. That’s the National Cancer Institute’s general advice for nausea.
  • Cold or bland food, and few smells. Sip a cold drink, avoid cooking or eating strong-smelling foods, and choose mild dishes such as toast, baked chicken or fish, potatoes, pasta or rice.
  • Ginger, if you like it. The NHS and the advisory mention it, as a tea or in food. It’s practical advice, not a result from GLP-1 trials.
  • Fluids in sips, not a big glass with your plate. Drinking enough still matters: the Wegovy and Zepbound Medication Guides say drinking fluids helps reduce your chance of dehydration.
  • Don’t lie down after eating, and skip clothes that are tight around the waist.
  • No alcohol, no fizz. The advisory says alcohol can worsen nausea on GLP-1 medications, and MedlinePlus also suggests avoiding caffeine and carbonated drinks.

What to try depending on when nausea hits

If you feel sick… Why it tends to happen What to try
In the morning or after many hours without food The 2025 advisory notes it often shows up then; not eating can make it worse A small, bland breakfast (yogurt, toast, an egg), a cold drink in sips, and another small snack 3 to 4 hours later
After eating Your stomach empties more slowly, so a large or fatty meal sits heavier A smaller plate, eating slowly, stopping at the first sign of fullness, little liquid with the meal, not lying down
After a dose increase The labels place most digestive side effects in the dose-escalation period Go back to minimal, bland meals for those days, keep up fluids, and tell your prescriber if you can’t eat or drink normally

The US labels give prescribers room to adjust: the Wegovy label says that if a dose isn’t tolerated during escalation, prescribers can consider delaying the next increase, and the Zepbound label that if a maintenance dose isn’t tolerated, they can consider a lower one. That’s their call, so tell your prescriber how you’re doing before the next step up.

12 easy-to-digest foods and their protein

When you’re eating little, it helps if that little brings protein. These 12 foods from our database carry the “easy to digest” tag, an editorial classification based on general guidance for nausea. Most are very low in fat; ricotta, whole-milk Greek yogurt and eggs have a bit more, so see which ones sit best with you. Meat and fish are weighed raw; rice, potato and oatmeal, cooked. US cup measures are approximate.

Food Serving Protein Fat Energy
Turkey breast, skinless 100 g (3.5 oz) 23.7 g 1.5 g 114 kcal
Chicken breast, skinless 100 g (3.5 oz) 22.5 g 2.6 g 120 kcal
Atlantic cod 100 g (3.5 oz) 17.8 g 0.7 g 82 kcal
Light tuna, canned in water, drained 60 g (2.1 oz) 15.3 g 0.5 g 70 kcal
Ricotta, part-skim 100 g (a scant ½ cup) 11.4 g 7.9 g 138 kcal
Greek yogurt, plain, whole milk 125 g (about ½ cup) 11.3 g 6.3 g 121 kcal
Cottage cheese, 2% 100 g (a scant ½ cup) 10.4 g 2.3 g 81 kcal
Egg, whole 1 egg (55 g) 6.9 g 5.2 g 79 kcal
Oatmeal, cooked with water 200 g (a scant cup) 5.1 g 3.0 g 142 kcal
White rice, cooked 150 g (about 1 cup) 4.0 g 0.4 g 195 kcal
Potato, boiled 150 g (5.3 oz, one small potato) 2.8 g 0.2 g 131 kcal
Banana 120 g (one medium) 1.3 g 0.4 g 107 kcal

Composition data: USDA FoodData Central, as used in the food pages (in Spanish). Servings are a guide, not a recommendation. The full list is in easy-to-digest foods (in Spanish).

Two simple combinations: 60 g (2.1 oz) of tuna with 150 g (about 1 cup) of rice adds up to 19.3 g of protein; 100 g (3.5 oz) of cod with 150 g of potato, 20.6 g. To estimate how much you need a day, try the protein calculator (in Spanish; it works in kilograms, so divide your weight in pounds by 2.2). If you’re worried about losing muscle, I explain it in protein and muscle on GLP-1 medications.

What not to do

  • Skipping meals altogether. The advisory describes a loop: you don’t eat because of the nausea, that makes it worse, and you eat even less. A tiny snack beats nothing.
  • Forcing big meals to make up for it. The same advisory warns that vomiting is more likely after large meals.
  • Changing your dose on your own. Delaying, skipping or lowering a dose is a decision for your prescriber.
  • Self-medicating. The advisory mentions that antiemetics (anti-nausea medicines) can bring relief while you adjust, but some make constipation worse. Ask your prescriber or pharmacist before taking any, including over-the-counter ones.
  • Cutting back on fluids. Both US labels report postmarketing cases of acute kidney injury, mostly in people whose nausea, vomiting or diarrhea led to dehydration.

If you’ve been eating so little for days that the basics are hard to cover, or food has become a source of anxiety, talk to your prescriber or a registered dietitian. And if you’re also constipated, I cover that in constipation on GLP-1 medications.

When to call your prescriber right away

When to call your doctor

Severe stomach pain. Acute pancreatitis (inflammation of the pancreas) was rare in the weight-management trials: the Wegovy label reports 4 adjudication-confirmed cases on Wegovy (0.2 per 100 patient-years) versus 1 on placebo (under 0.1), and the Zepbound label 0.2% on Zepbound versus 0.2% on placebo. Still, it’s the symptom not to sit on. The Wegovy and Zepbound Medication Guides describe it this way: severe pain in your stomach area (abdomen) that will not go away, with or without nausea or vomiting, sometimes felt from your abdomen through to your back, means calling your healthcare provider right away.

Vomiting that won’t stop. MedlinePlus says to call your provider if you can’t keep food or liquids down, vomit 3 or more times in a day, or go 8 hours or more without urinating. The Medication Guides add that nausea, vomiting or diarrhea that does not go away should be reported to your healthcare provider right away.

Signs of dehydration. The NHS lists thirst, headache, dark and strong-smelling urine, peeing less often than usual, dizziness, tiredness, a dry mouth and lips, and sunken eyes.

Nausea with chest pain. The NHS says to call emergency services (911 in the US) if sudden nausea comes with chest pain that feels tight or heavy, pain spreading to the arms, back, neck or jaw, or shortness of breath. It could be a heart attack.

Frequently asked questions

How long does nausea last on Wegovy or Zepbound?

With Wegovy, the median was 8 days, according to the EU prescribing information. The US labels don’t give a duration, but the Zepbound label says nausea decreased over time. If it keeps you from eating, talk to your prescriber.

Is it normal to feel sick after a dose increase?

Yes. Both labels place most digestive side effects in the dose-escalation period, and with semaglutide they peaked around week 20.

Does more nausea mean the medication is working better?

There’s no evidence for that. In STEP 1 to 3, weight loss with semaglutide was similar with and without digestive side effects, which explained less than 1 percentage point of the difference from placebo. In SURMOUNT-1 to -4, weight loss with tirzepatide was similar with and without nausea; digestive side effects explained, at most, a small part of it.

Which causes more nausea, Wegovy or Zepbound?

The labels don’t let you compare them, because the figures come from different trials. With both, nausea is very common and almost always mild or moderate. Which treatment fits you is a decision to make with your prescriber.

Can I take something for nausea?

According to the 2025 advisory, some anti-nausea medicines can help while you adjust, but not all are a good fit. Don’t self-medicate: ask your prescriber or pharmacist, who know the rest of your treatment.

Sources

Sources consulted for this article, with the access date.

  1. Drug labelWegovy (semaglutide) injection and tablets: US Prescribing Information and Medication Guide (sections 2.2, 5.2, 5.5, 5.6, 6.1, 12.2, 17). U.S. Food and Drug Administration label, via DailyMed (National Library of Medicine). accessed .
  2. Drug labelZepbound (tirzepatide) injection: US Prescribing Information and Medication Guide (sections 2.1, 5.2, 5.3, 5.5, 6.1, 12.2, 17). U.S. Food and Drug Administration label, via DailyMed (National Library of Medicine). accessed .
  3. Drug labelMounjaro (tirzepatide) injection: US Prescribing Information (section 6.1). U.S. Food and Drug Administration label, via DailyMed (National Library of Medicine). accessed .
  4. Drug labelOzempic (semaglutide) injection: US Prescribing Information (section 6.1). U.S. Food and Drug Administration label, via DailyMed (National Library of Medicine). accessed .
  5. Drug labelWegovy (semaglutide): EU Summary of Product Characteristics, section 4.8 (median duration of gastrointestinal reactions). European Medicines Agency. accessed .
  6. Drug labelMounjaro (tirzepatide): EU Summary of Product Characteristics, section 4.8 (severity of gastrointestinal reactions in the weight-management trial). European Medicines Agency. accessed .
  7. Clinical trialWharton S, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24(1):94-105. Diabetes, Obesity and Metabolism. accessed .
  8. Clinical trialRubino DM, et al. Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT-1 to -4 trials. Diabetes Obes Metab. 2025;27(4):1826-1835. Diabetes, Obesity and Metabolism. accessed .
  9. Clinical guidelineMozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from ACLM, ASN, OMA and The Obesity Society. Obesity. 2025;33(8):1475-1503. Obesity (The Obesity Society, Wiley). accessed .
  10. Other sourceAlhazmi A, le Roux CW. Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies (opinion article). Front Endocrinol. 2026;17:1788698. Frontiers in Endocrinology. accessed .
  11. InstitutionFeeling sick (nausea). NHS (UK National Health Service). accessed .
  12. InstitutionDehydration. NHS (UK National Health Service). accessed .
  13. InstitutionWhen you have nausea and vomiting. MedlinePlus, U.S. National Library of Medicine (NIH). accessed .
  14. InstitutionNausea and Vomiting and Cancer Treatment. National Cancer Institute (NIH). accessed .
  15. Official databaseFoodData Central (per-100 g values for each food cited in the /alimentos/ food pages). U.S. Department of Agriculture, Agricultural Research Service. accessed .